Peroxide formation in polysorbate 80 and protein stability.

Nonionic surfactants are widely used in the development of protein pharmaceuticals. However, the low level of residual peroxides in surfactants can potentially affect the stability of oxidation-sensitive proteins. In this report, we examined the peroxide formation in polysorbate 80 under a variety of storage conditions and tested the potential of peroxides in polysorbate 80 to oxidize a model protein, IL-2 mutein. For the first time, we demonstrated that peroxides can be easily generated in neat polysorbate 80 in the presence of air during incubation at elevated temperatures. Polysorbate 80 in aqueous solution exhibited a faster rate of peroxide formation and a greater amount of peroxides during incubation, which is further promoted/catalyzed by light. Peroxide formation can be greatly inhibited by preventing any contact with air/oxygen during storage. IL-2 mutein can be easily oxidized both in liquid and solid states. A lower level of peroxides in polysorbate 80 did not change the rate of IL-2 mutein oxidation in liquid state but significantly accelerated its oxidation in solid state under air. A higher level of peroxides in polysorbate 80 caused a significant increase in IL-2 mutein oxidation both in liquid and solid states, and glutathione can significantly inhibit the peroxide-induced oxidation of IL-2 mutein in a lyophilized formulation. In addition, a higher level of peroxides in polysorbate 80 caused immediate IL-2 mutein oxidation during annealing in lyophilization, suggesting that implementation of an annealing step needs to be carefully evaluated in the development of a lyophilization process for oxidation-sensitive proteins in the presence of polysorbate.

[1]  M. Gallarate,et al.  Emulsions containing partially water-miscible solvents for the preparation of drug nanosuspensions. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[2]  C. Schöneich,et al.  Oxidative degradation of pharmaceuticals: theory, mechanisms and inhibition. , 2001, Journal of pharmaceutical sciences.

[3]  C K Kim,et al.  Preparation and evaluation of biphenyl dimethyl dicarboxylate microemulsions for oral delivery. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[4]  J. H. Kou,et al.  Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[5]  Christopher A. Carter,et al.  A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo , 2000, Nature Biotechnology.

[6]  Wei Wang Lyophilization and development of solid protein pharmaceuticals. , 2000, International journal of pharmaceutics.

[7]  M. Hageman,et al.  Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-drying. , 1999, Journal of pharmaceutical sciences.

[8]  E. Topp,et al.  Solid-state chemical stability of proteins and peptides. , 1999, Journal of pharmaceutical sciences.

[9]  B. Chang,et al.  Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. , 1996, Journal of pharmaceutical sciences.

[10]  A. Hagman,et al.  Oxidation of Human Insulin-Like Growth Factor I in Formulation Studies, II. Effects of Oxygen, Visible Light, and Phosphate on Methionine Oxidation in Aqueous Solution and Evaluation of Possible Mechanisms , 1996, Pharmaceutical Research.

[11]  Kent Axelsson,et al.  Oxidation of Human Insulin-like Growth Factor I in Formulation Studies: Kinetics of Methionine Oxidation in Aqueous Solution and in Solid State , 1996, Pharmaceutical Research.

[12]  R. S. Payne,et al.  Freeze-drying: in situ observations using cryoenvironmental scanning electron microscopy and differential scanning calorimetry. , 1996, Journal of pharmaceutical sciences.

[13]  T. Calderwood,et al.  Identification of antioxidants for prevention of peroxide-mediated oxidation of recombinant human ciliary neurotrophic factor and recombinant human nerve growth factor. , 1996, PDA journal of pharmaceutical science and technology.

[14]  T. Arakawa,et al.  The Effect of the Reconstitution Medium on Aggregation of Lyophilized Recombinant Interleukin-2 and Ribonuclease A , 1996, Pharmaceutical Research.

[15]  Steven J. Prestrelski,et al.  A New Strategy for Enhancing the Stability of Lyophilized Protein: The Effect of the Reconstitution Medium on Keratinocyte Growth Factor , 1995, Pharmaceutical Research.

[16]  L. Bell,et al.  Effect of surfactants on the physical stability of recombinant human growth hormone. , 1995, Journal of pharmaceutical sciences.

[17]  K. Son,et al.  Stabilization of Human Epidermal Growth Factor (hEGF) in Aqueous Formulation , 1995, Pharmaceutical Research.

[18]  S. Wolff,et al.  Peroxide accumulation in detergents. , 1994, Journal of biochemical and biophysical methods.

[19]  S. Yoshioka,et al.  Effect of mannitol crystallinity on the stabilization of enzymes during freeze-drying. , 1994, Chemical & pharmaceutical bulletin.

[20]  S. Yoshioka,et al.  Decreased Protein-Stabilizing Effects of Cryoprotectants Due to Crystallization , 1993, Pharmaceutical Research.

[21]  K Sasaoki,et al.  Deamidation at asparagine-88 in recombinant human interleukin 2. , 1992, Chemical & pharmaceutical bulletin.

[22]  Y. Orii,et al.  The reaction of horseradish peroxidase with hydroperoxides derived from Triton X-100. , 1985, Analytical biochemistry.

[23]  W. Taylor,et al.  Degradation of fenprostalene in polyethylene glycol 400 solution. , 1984, Journal of pharmaceutical sciences.

[24]  Juan C. Scaiano,et al.  Rate constants for the reactions of free radicals with oxygen in solution , 1983 .

[25]  H. W. Chang,et al.  Pitfalls in the use of commercial nonionic detergents for the solubilization of integral membrane proteins: sulfhydryl oxidizing contaminants and their elimination. , 1980, Analytical biochemistry.

[26]  M. Donbrow,et al.  Autoxidation of polysorbates. , 1978, Journal of pharmaceutical sciences.

[27]  T. R. Bates,et al.  Kinetics of hydrolysis of polyoxyethylene (20) sorbitan fatty acid ester surfactants , 1973, The Journal of pharmacy and pharmacology.

[28]  R. H. Leach,et al.  A stability study of chloramphenicol in topical formulations * , 1970, The Journal of pharmacy and pharmacology.

[29]  H. Rawls,et al.  A possible role for singlet oxygen in the initiation of fatty acid autoxidation , 1970 .

[30]  L. Coates,et al.  THE STABILITY OF ANTIBACTERIALS IN POLYETHYLENE GLYCOL MIXTURES , 1961, The Journal of pharmacy and pharmacology.

[31]  H Leuenberger,et al.  Effects of formulation and process variables on the aggregation of freeze-dried interleukin-6 (IL-6) after lyophilization and on storage. , 1998, Pharmaceutical development and technology.

[32]  T. Randolph,et al.  Molten Globule Intermediate of Recombinant Human Growth Hormone: Stabilization with Surfactants , 1996, Biotechnology progress.

[33]  T. Boone,et al.  Characterization, formulation, and stability of Neupogen (Filgrastim), a recombinant human granulocyte-colony stimulating factor. , 1996, Pharmaceutical biotechnology.

[34]  W. Gombotz,et al.  Stability, characterization, formulation, and delivery system development for transforming growth factor-beta 1. , 1996, Pharmaceutical biotechnology.

[35]  M. Pikal,et al.  Formulation and stability of freeze-dried proteins: effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone. , 1992, Developments in biological standardization.

[36]  R. K. Rana,et al.  Development of a lyophilized formulation of interleukin-2. , 1992, Developments in biological standardization.

[37]  M. Donbrow,et al.  Autoxidation of polyoxyethylenic non-ionic surfactants and of polyethylene glycols. , 1975, Pharmaceutica acta Helvetiae.